Skip to content
Johnson Pharmacare logo

Johnson Pharmacare

532154 BSE
₹0.54

Close ·

P/E
Not meaningful: loss-making over the last twelve months
View as Markdown
MCP
Close 4 Nov 2026 ₹0.54 −0.09 −14.3% 1Y
Start ₹0.63

Key Fundamentals

MicrocapCommercial ServicesServices

Price-based figures at the close · EPS basis: Standalone · TTM

ROCE
−105.00%
Debt to Equity
Not meaningful: shareholders’ equity is negative
EPS (TTM)
−₹1.03
Book Value
₹0.01
Market Cap
—
P/E (TTM)
Not meaningful: loss-making over the last twelve months
P/B
54.00
ROE
Not meaningful: shareholders’ equity is negative
Dividend Yield
0.00%
EBITDA
−₹57.05 Cr
52W High
₹0.70
52W Low
₹0.36

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

29 Poor

Data confidence 77/100

Category scores

Quality
22
Poor
Returns, margins, earnings quality 24% weight
Valuation
17
Poor
Cheap vs sector & own history 26% weight
Financial Health
1
Poor
Solvency, leverage, coverage 10% weight
Momentum
69
Strong
Trend strength, vol-adjusted 13% weight
Ownership
50
Average
FII/DII/promoter flows 26% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

No strengths listed

Weaknesses

3
  • Stock is trading at 55.0 times its book value
  • Company has low interest coverage ratio.
  • Company has a low return on equity of -29.6% over last 3 years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish4213
OscillatorsBearish423
Moving AveragesStrong Bullish0010

Key readings

RSI (14)
74.46
Bearish
MACD (12,26,9)
0.00
Bullish
SMA (50)
0.44
Bullish
SMA (200)
0.50
Bullish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10YZero base
5Y−100.00%
3Y−100.00%
1YZero base
TTMZero base

Net profit

Net profit growth by window
10YTurned to loss
5YTurned to loss
3YLoss widened by ₹55 Cr
1YLoss widened by ₹55 Cr
TTMLoss widened by ₹56.18 Cr

Operating cash flow

Operating cash flow growth by window
10YOutflow widened by ₹46 Cr
5YTurned negative
3YTurned negative
1YOutflow widened by ₹55 Cr
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10YNo sales
5YNo sales
3YNo sales
1YNo sales
TTMNo sales

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹0.00 Cr
Mar 2018₹0.00 Cr
Mar 2019₹1.00 Cr
Mar 2020₹0.00 Cr
Mar 2021₹1.00 Cr
Mar 2022₹3.00 Cr
Mar 2023₹3.00 Cr
Mar 2024₹0.00 Cr
Mar 2025₹0.00 Cr
Mar 2026₹0.00 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹0.00 Cr
Mar 2018₹0.00 Cr
Mar 2019₹0.00 Cr
Mar 2020₹0.00 Cr
Mar 2021₹0.00 Cr
Mar 2022₹0.00 Cr
Mar 2023−₹1.00 Cr
Mar 2024₹0.00 Cr
Mar 2025−₹1.00 Cr
Mar 2026−₹56.00 Cr

Quarterly Results

₹ Cr
532154 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
0
0
0
0
0
0
0
0
0
0
0
0
Expenses
0.19
0
0
0
0.04
0
0.03
0.01
0.05
0
0.02
42.7
0.04
Operating Profit
−0.19
0
0
0
−0.04
0
−0.03
−0.01
−0.05
0
−0.02
−42.7
−0.04
Other Income
0
0
0
0
0
0
0
−0.5
0
0
0
−12.69
0
Interest
0
0
0
0
0
0
0
0
0
0
0.04
0.22
1.06
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
−0.19
0
0
0
−0.04
0
−0.03
−0.51
−0.05
0
−0.06
−55.61
−1.1
Tax %
0%
—
—
—
0%
—
0%
0%
0%
—
0%
0%
0%
Net Profit
−0.19
0
0
0
−0.04
0
−0.03
−0.51
−0.05
0
−0.06
−55.61
−1.1
EPS (₹)
0
0
0
0
0
0
0
−0.01
0
0
0
−1.01
−0.02

Profit & Loss

₹ Cr
532154 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
0
0
0
1
0
1
3
3
0
0
0
0
Expenses
0
0
0
0
1
0
1
3
2
0
0
43
43
Operating Profit
0
0
0
0
0
0
0
0
0
0
0
−43
−43
OPM %
—
—
—
—
−1.1%
—
0%
4%
9%
—
—
—
—
Other Income
0
0
0
0
0
0
0
0
−2
0
0
−13
−13
Interest
0
0
0
0
0
0
0
0
0
0
0
0
1
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
0
0
0
0
0
0
0
−1
0
−1
−56
−57
Tax %
0%
0%
0%
0%
0%
0%
—
31%
−3%
0%
0%
0%
—
Net Profit
0
0
0
0
0
0
0
0
−1
0
−1
−56
−57
EPS (₹)
0
0
0
0
0
0
0
0
−0.02
0
−0.01
−1.01
−1.03
Div. Payout %
0%
0%
0%
0%
0%
0%
—
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
532154 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
50
50
50
50
50
50
50
55
55
55
55
55
Reserves
8
8
8
8
8
8
8
3
2
2
1
−55
Borrowings
1
1
1
2
2
1
1
1
2
2
1
21
Other Liabilities
0
0
0
0
0
0
1
1
1
1
1
0
Total Liabilities
60
59
59
60
60
59
59
60
60
60
58
22
Fixed Assets
0
0
0
0
0
0
0
0
0
0
0
0
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
54
43
54
54
53
52
52
54
46
46
42
20
Other Assets
6
16
5
6
7
7
7
6
14
14
16
2
Total Assets
60
59
59
60
60
59
59
60
60
60
58
22

Cash Flow

₹ Cr
532154 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
8
−11
11
−1
−1
0
0
5
0
0
−2
−57
Investing
10
11
−11
0
1
1
0
−5
−1
0
3
58
Financing
2
0
0
1
0
−1
0
0
1
0
−1
0
Net Cash Flow
21
0
0
0
0
0
0
0
0
0
0
0
Free Cash Flow
8
−11
11
−1
−1
0
0
5
0
0
−2
−57
CFO/OP
−41,350
8,385
−8,200
1,417
9,300
−189
—
3,800
−200
25
764
134

Ratios

532154 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
—
—
—
365
—
807
118
0
—
—
—
Inventory Days
—
—
—
—
—
—
0
0
0
—
—
—
Cash Conversion Cycle
—
—
—
—
365
—
807
118
0
—
—
—
Working Capital Days
—
—
—
—
1,932
—
2,267
−9
−141
—
—
—
ROCE %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
−105%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Johnson Pharmacare insights

56 extracted metrics across FY10–FY27.

Shareholding Pattern

As of Jun 2026

  • Public 85.56%
  • Others 14.44%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Johnson Pharmacare

What does Johnson Pharmacare Ltd do?
Johnson Pharmacare Limited, formerly Sun and Shine Worldwide Limited, is an investment-focused listed company with no demonstrated pharmaceutical operations.
Where is Johnson Pharmacare Ltd (JOHNPHARMA) listed?
Johnson Pharmacare Ltd trades under code 532154 on the BSE.
Which sector does Johnson Pharmacare Ltd belong to?
Johnson Pharmacare Ltd is classified under the Commercial Services sector, in the Diversified Services industry.
What is the 52-week high and low of Johnson Pharmacare Ltd?
Over the last 52 weeks Johnson Pharmacare Ltd has traded between ₹0.36 and ₹0.7 as of 4 Nov 2026.

Company Information

Johnson Pharmacare Limited, formerly Sun and Shine Worldwide Limited, is an investment-focused listed company with no demonstrated pharmaceutical operations.

Website sunandshineworldwidetradelimited.in
Face Value ₹1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/532154.md for Johnson Pharmacare Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Commercial Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month